Articles On Actinogen Medical (ASX:ACW)

Title Source Codes Date
ScoPo’s Powerplays: ASX health stocks rise amid renewed positive sentiment

ASX health stocks rise 2% in past five days as broader markets lift 0.6% Morgans upgrades disinfectant device maker Nanosonics after positive trading update  Neuren receives rare paediatric disease designation from FDA for NNZ-2591 in Phel...

Stockhead ACW 11 hours ago
Here's why A2 Milk shares soared in FY24. Will it happen again?

A2 Milk Company Ltd (ASX: A2M) shares ended up having a stellar finish to the year in FY24. In total, shares in the specialty milk company rose 38%, starting the year at $4.89 and closing the period at $6.77 apiece. Most of this was...

Motley Fool ACW 1 week ago
A2 Milk shares lift amid backing for $130 million Synlait loan

A2 Milk Co Ltd (ASX: A2M) shares are in the green today. Shares in the S&P/ASX 200 Index (ASX: XJO) dairy stock closed yesterday trading for $6.82. In morning trade on Thursday, shares are swapping hands for $6.88, up 0.8%. For so...

Motley Fool ACW 1 week ago
ACWN ASX | Actinogen Medical Ltd | Market Insights, News

Livewire ACW 1 week ago
ASX Health June Winners: Actinogen and Optiscan led a sector in good shape

The ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biotechs in June were Actinogen, Optiscan and EZZ Life Science, amongst others    The S&P/ASX 200 Health Care index [XHJ] saw a 4% increase...

Stockhead ACW 2 weeks ago
ASX Health Stocks: Immuron files pre-IND application with FDA

IMM files a pre-IND application with US FDA for IMM-529 targeting common pathogen clostridioides difficile Ansell completes 100% acquisition of the assets of US giant Kimberly-Clark Corporation’s personal protective business Actinogen Xana...

Stockhead ACW 2 weeks ago
ASX June Winners: The best 50 stocks as inflation spikes

S&P/ASX 200 rose 1% in June with large caps leading gains with mid, small and emerging companies lagging S&P/ASX 200 financials and consumer staples were the top performers in June with materials the biggest laggard Urea fertiliser...

Stockhead ACW 2 weeks ago
New money sends InteliCare share price flying

This week’s Bulls N’ Bears Runner of the Week is … InteliCare Holdings. Its share price jumped 144 per cent on a capital raise, as Encounter Resources, Vonex and Actinogen Medical also compiled solid ASX runs.

The West ACW 3 weeks ago
Closing Bell: Benchmark trims gains ahead of US inflation tonight and month end portfolio positioning

  ASX 200 hit by afternoon profit taking, closing at +0.1pc for the day. 9 of 11 ASX sectors were higher, so… two of them weren’t. Small cap gains led by East33, and the world is their oyster.   Local markets trimmed most of the early mor...

Stockhead ACW 3 weeks ago
Closing Bell: Abominable inflation has ASX in full retreat

ASX200 falls fast for a second session after inflation steals the air in the room 7 of 11 ASX sectors lower, with InfoTech the only standout in the plus column Small caps led by Iris Metals and Bellavista Resources   Local markets have...

Stockhead ACW 3 weeks ago
Macquarie names 6 ASX shares to buy in July after tax-loss selling

Tax-loss selling could be pile-driving fundamentally good companies into the ground. At least, that's what analysts at Macquarie think, prompting the team to name a handful of ASX shares to buy following the indiscriminate tax-driven sellin...

Motley Fool ACW 3 weeks ago
Here are the top 10 ASX 200 shares today

It was an unpleasant Wednesday for the S&P/ASX 200 Index (ASX: XJO) and most ASX shares this hump day. After enjoying a strong session yesterday, investors reversed course to...

Motley Fool ACW 3 weeks ago
Closing Bell: It’s gotta be bonds after ASX pantsed by lingering inflation, fears of August rate hike

ASX falls 0.7pc on sticky CPI read Consumer Discretionary stocks dragged down by CKF and HVN Top small cap performers  include Metallica and Actinogen Medical   Bond yields soared and the ASX200 seemed to hit terminal velocity at around...

Stockhead ACW 3 weeks ago
Closing Bell: It’s gotta be bonds after ASX pantsed by lingering inflation, fears of August rate hike

ASX falls 0.7pc on sticky CPI read Consumer Discretionary stocks dragged down by CKF and HVN Top small cap performers  include Metallica and Actinogen Medical   Bond yields soared and the ASX200 seemed to hit terminal velocity at around...

Stockhead ACW 3 weeks ago
Actinogen’s Xanamem could slow Alzheimer’s progress, new biomarker trial reveals

A biomarker trial of Actinogen Medical’s (ASX: ACW) lead candidate Xanamem has been published in the peer-reviewed Journal of Alzheimer’s Disease, with results showing the drug has the potential to slow disease progression in patients with...

SmallCaps ACW 3 weeks ago
Why A2 Milk, Actinogen Medical, Karoon Energy, and Race Oncology shares are rising

The S&P/ASX 200 Index (ASX: XJO) is having a tough time on Wednesday after a stronger than expected inflation reading. In afternoon trade, the benchmark index is down 1% to 7,758.4 points. Four ASX shares that are not letting that hold...

Motley Fool ACW 3 weeks ago
The ASX 200 just plummeted on May's inflation figures. Here's why

After closing up 1.4% on Tuesday, the S&P/ASX 200 Index (ASX: XJO) looks ready to give back most of those gains today. The benchmark index was down 0.5% at 11.30am AEST. Then, the Australian Bureau of Statistics (ABS) released May's Au...

Motley Fool ACW 3 weeks ago
ASX Health Winners in May: LTR Pharma leads, and why hopes are high for biotech stocks this year

 S&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biotech stocks We take a look at the ASX biotech winners for the month   The  S&P/ASX 200 Health Care [XHJ] closed flattish for the month o...

Stockhead ACW 1 month ago
Actinogen says entitlement offer closed and oversubscribed

Actinogen Medical (ASX:ACW) has announced the successful completion of its non-renounceable 1-for-15 entitlement offer to raise up to $3.9 million.

BiotechDispatch ACW 1 month ago
Check Up: Alzheimer’s is ‘preventable’, so here’s what you must do; and recent ASX biotech winners

Research shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase the risk of dementia We look at the best performing ASX stocks over the past month    The phrase ‘you are what you eat’ was coined almost a c...

Stockhead ACW 1 month ago
Market Close: ASX holds green gains and signs off in the sunshine

The ASX200 closed .6 of a per cent up with every sector finishing in the green and consumer discretionary the star of the show. In the green Consumer discretionary giants shot up today, the sector was up more than 2% – with Wesfar...

themarketonline.com.au ACW 2 months ago
Top 10 at 10: ‘Outstanding’ lithium hits and a $30m ADF cash splash

Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead ACW 2 months ago
ASX Health Winners April: Mesoblast leads; and why the Health sector is just built different

ASX Health sector was in correction territory in April Why is the health sector different from other sectors? We look at the best performing ASX health stocks for the month   The S&P/ASX 200 Health Care [XHJ] had a soft month in April...

Stockhead ACW 2 months ago
Closing Bell: ASX meltdown as market awaits Fed; uranium diggers rebound

The ASX has plunged alongside Wall Street on jitters of higher US rates for longer All 11 sectors closed in the red Uranium stocks gathered some ground today   The ASX200 has tumbled over 1% on Wednesday as hot US labour data sent jitters...

Stockhead ACW 2 months ago
Check Up: Big breakthrough in acne treatment, and recent ASX biotech winners

There’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to control sebum production We look at the best and worst performing ASX health stocks in the past month   Scientists have made a significant b...

Stockhead ACW 2 months ago
First patient treated in Actinogen’s XanaMIA phase 2b Alzheimer’s disease trial

Plus, Actinogen receives approval of its application for a UK Innovation Passport as part of the Innovative Licensing and Access Pathway (ILAP) for Xanamem in the treatment of Alzheimer’s disease Enrolment in XanaCIDD phase 2a trial of c...

FNArena ACW 3 months ago
Actinogen Medical launches Alzheimer’s trial to test impact of Xanamem on cognitive health

Actinogen Medical (ASX: ACW) has treated the first subject in its clinical trial of patients with biomarker-positive mild to moderate Alzheimer’s disease. The XanaMIA Phase 2b trial involves 220 participants with elevated levels of the bloo...

smallcapsau.mystagingwebsite.com ACW 3 months ago
ASX Health Stocks: Atomo sells more HIV Self-Tests; Actinogen begins Phase 2b trial on Alzheimer’s

Atomo announces more purchase orders for HIV Self-Tests Actinogen says first patient was treated in Alzheimer’s disease study Imugene has opened enrolment for expansion study in solid tumours   Atomo sells more HIV self-test kits Atomo Di...

Stockhead ACW 3 months ago
The next Neuren? Nyrada chases after two big markets – stroke and traumatic brain injury

Nyrada jumped 400pc in a single day last month The company reported good results from its Brain Injury Program Could Nyrada be the next Neuren?   Nyrada’s 400% share price rally on February 28 was the biggest single day jump of any ASX st...

Stockhead ACW 4 months ago
ASX Health Winners February: Law of attrition applies but biotech is a long term game; Nyrada up 5x last month

ASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essentially, biotech is a long term game for investors   The S&P/ASX 200 Health Care [XHJ] struggled in February, finishing -1.5% lower and tr...

Stockhead ACW 4 months ago
Research To Download: Bell Financial, Cash Converters, EML Payments, Freelancer, & More!

Research reports on ASX-listed companies, to download in full. **** -Actinogen Medical ((ACW)) by Edison Research: https://www.fnarena.com/index.php/download-article/?n=17DBBDB4-E20C-03AC-A84AF5C456D084E9 -Amaero International ((3DA)) by Re...

FNArena ACW 4 months ago
Check Up: Big week in world of biotech after these 2 Nasdaq stocks announce breakthroughs

Viking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on pancreatic cancer results We look at the recent best performing ASX health stocks   There were a couple of big news from the world of biotec...

Stockhead ACW 4 months ago
Diagnosing mental disorder through sleep: How TrivarX could capture this huge research market

One in eight people in the world have some form of mental disorder TrivarX’s AI technology diagnoses mental health via sleep monitoring Stockhead reached out to TrivarX’s COO, Kai Sun   Mental health has always been a big global issue, bu...

Stockhead ACW 4 months ago
Closing Bell: Local markets ride commodities higher after a blow to US confidence on Friday

  Local markets ride commodities lift to offset weak performance from Wall Street on Friday ASX 200 benchmark finished the day on +0.09pc, a lot higher than it really had any right to Resources led the way, overcoming a significant deadwei...

Stockhead ACW 5 months ago
Closing Bell: ASX ends it like Beckham… lower and with a pretty whimper, which could still suggest good things ahead

The ASX benchmark has closed slightly lower on Friday Losses across the Energy Sector weighed Small caps led ID8   The Aussie sharemarket has ended lower on Friday, driven to a small disgrace by the ongoing declines in oil prices – down...

Stockhead ACW 8 months ago
In Case You Missed It: Education software, gold exploration and a dairy deal

Stockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might have slipped beneath your radar. Below is a wrap of the top 20 performing stocks, by percentage, that made announcements today.   ICYMI Leade...

Stockhead ACW 8 months ago
Check Up: Biden-Xi meeting could finally end opioids crisis in the US; and recent ASX biotech winners

Xi and Biden set to agree on restricting fentanyl  Fentanyl is a synthetic opioid responsible for the opioids epidemic in the US We look at the best performing health stocks over the past couple of weeks   China’s President Xi is expected...

Stockhead ACW 8 months ago
Closing Bell: Broad-based whinging leads ASX back to the start of 2023, minus the hope and ignorance

The ASX has ended -0.4% lower, just 2.5 points from 2023 parity Utilities only sector in green Small caps led by 4DX, Infinity and a few Lake Johnston lithium plays   The local market is back to digging its little hole from which it may t...

Stockhead ACW 8 months ago
Research To Download: Actinogen, Freelancer, Lepidico, State Gas, & More

Research reports on ASX-listed companies, to download in full. **** -Actinogen Medical ((ACW)) by Research as a Service (RaaS): https://www.fnarena.com/index.php/download-article/?n=2B537F21-A3D7-CB04-98294578CBAE8E12 -Amaero International ...

FNArena ACW 8 months ago
In Case You Missed It: A software player takeover and astronaut food launch in Malaysia

Stockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might have slipped beneath your radar. Below is a wrap of the top 20 performing stocks, by percentage, who made announcements today.   ICYMI Leader...

Stockhead ACW 8 months ago
Check Up: Why Goldman Sachs won’t change its ratings on 3 ASX stocks despite Ozempic-driven selloff

News relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD fell heavily last week But Goldman analysts say they won’t change ratings on these 3 stocks   Goldman Sachs analysts said they will make no...

Stockhead ACW 9 months ago
Actinogen to present progress on Phase 2 trials at the BIO Investor Forum, San Francisco and Clinical Trials on Alzheimer’s Disease (CTAD) Conference, Boston

Xanamem® is an oral, brain-penetrant tissue cortisol synthesis inhibitor that has shown promising safety and clinical activity in three placebo-controlled trials and has the potential to treat a variety of neurodegenerative and neuropsyc...

FNArena ACW 9 months ago
Closing Bell: War footing suits ASX as Fed frees a dove

Benchmark ASX index finishes +1% higher ASX Sectors led by Utilities (+4.2%) and all ended higher on the day Funny bunch of small cap winners including MOB, CZR, NGL   The ASX200 doesn’t seem to mind a bit of war on Tuesday, rising very...

Stockhead ACW 9 months ago
In Case You Missed It: Lithium acquisitions and bumper nickel processing for Q3

Stockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might have slipped beneath your radar. Below is a wrap of the top 20 performing stocks, by percentage, who made announcements today.   ICYMI Leader...

Stockhead ACW 9 months ago
Check Up: How supramolecular technology is used in biotech, and why L’Oréal wants to get its hands on it

L’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supramolecular technology which could be used in the fashion industry Best and worst performing ASX biotechs over the past couple of weeks   Be...

Stockhead ACW 9 months ago
Actinogen optimizes XanaMIA Phase 2b Alzheimer’s disease trial design and provides general business update

Highlights Changes to the XanaMIA protocol reduce cost by AUD 30 million over the next two years and speed time to initial results while preserving the 36-week design and trial endpoints. UK sites added to the XanaCIDD trial of cognitiv...

FNArena ACW 9 months ago
ASX closes 0.54% lower due to sell-off in tech and real estate stocks

On Tuesday, the Australian stock market experienced a decline primarily due to a sell-off in technology and real estate stocks. This drop is part of a broader trend where investors are adjusting their portfolios in anticipation of an extend...

ShareCafe ACW 9 months ago
In Case You Missed It: Visual spodumene and Covid clinical trials  

Stockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might have slipped beneath your radar. Below is a wrap of the top 20 performing stocks, by percentage, who made announcements today.   ICYMI Leader...

Stockhead ACW 9 months ago
ASX Health Stocks: Botanix Pharma plunges 25pc after FDA requests this minor change

US FDA requested Botanix to change its instructions paper Antisense says ATL1102 could be effective in muscular dystrophy Actinogen changes Phase 2b design to reduce cost and time to initial results   Botanix plunges after receiving FDA f...

Stockhead ACW 9 months ago
ASX down 0.49% at noon as Tech falls

The ASX opened lower by 0.4% on Tuesday, reflecting market adjustments in anticipation of prolonged higher interest rates. At noon, the S&P/ASX 200 is 0.49 per cent lower at 7,042.10, primarily driven by losses in property and tech sect...

ShareCafe ACW 9 months ago